Despite its poor prognosis, the pancreatic cancer treatment sector is seeing momentum through novel drug pipelines, clinical trials, and investment in oncology R&D. The report offers strategic insights for stakeholders targeting this high-risk disease space. https://www.datamintelligence.com/research-report/us-ophthalmology-amniotic-membrane-market